Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodynia.
暂无分享,去创建一个
S. Dib-Hajj | S. Waxman | J. Kocsis | K. Lankford | A. Tan | P. Zhao | Lubin Chen | Jianying Huang | Curtis A. Benson | Jennifer Carrara
[1] C. Kushida,et al. Peripheral neuropathy , 2005, Journal of Neurology.
[2] M. Sweet,et al. Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy , 2019, Front. Neurosci..
[3] D. Stainier,et al. Genetic compensation triggered by mutant mRNA degradation , 2019, Nature.
[4] Jun-Ming Zhang,et al. Neonatal vincristine administration modulates intrinsic neuronal excitability in the rat dorsal root ganglion and spinal dorsal horn during adolescence , 2018, Pain.
[5] Federico Iseppon,et al. Sodium channels , 2018, Brain and neuroscience advances.
[6] S. Collina,et al. Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead. , 2018, Bioorganic & medicinal chemistry letters.
[7] S. Dib-Hajj,et al. Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain , 2018, Scientific Reports.
[8] Ryan M. Cassidy,et al. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain , 2017, The Journal of Neuroscience.
[9] Jeffrey J. Nirschl,et al. The impact of cytoskeletal organization on the local regulation of neuronal transport , 2017, Nature Reviews Neuroscience.
[10] M. H. van den Berg,et al. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review. , 2017, Critical reviews in oncology/hematology.
[11] K. Aromolaran,et al. Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy , 2017, Molecular pain.
[12] I. Vetter,et al. Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy , 2017, Front. Mol. Neurosci..
[13] Wonseok Chang,et al. Expression and Role of Voltage-Gated Sodium Channels in Human Dorsal Root Ganglion Neurons with Special Focus on Nav1.7, Species Differences, and Regulation by Paclitaxel , 2017, Neuroscience Bulletin.
[14] J. Milbrandt,et al. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. , 2016, Brain : a journal of neurology.
[15] Shery Jacob,et al. A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.
[16] G. Cavaletti,et al. Chemotherapy-induced peripheral neurotoxicity. , 2015, Current opinion in neurology.
[17] E. Walters,et al. Mechanisms involved in the development of chemotherapy-induced neuropathy. , 2015, Pain management.
[18] W. Xie,et al. Local knockdown of the NaV1.6 sodium channel reduces pain behaviors, sensory neuron excitability, and sympathetic sprouting in rat models of neuropathic pain , 2015, Neuroscience.
[19] Elizabeth M. Wells,et al. Patterns and severity of vincristine‐induced peripheral neuropathy in children with acute lymphoblastic leukemia , 2015, Journal of the peripheral nervous system : JPNS.
[20] R. Baron,et al. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain , 2014, Nature Reviews Neurology.
[21] S. Bevan,et al. Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain. , 2014, The Journal of clinical investigation.
[22] S. Dib-Hajj,et al. Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H. , 2014, Journal of neurophysiology.
[23] S. Waxman,et al. Sodium Channels Contribute to Degeneration of Dorsal Root Ganglion Neurites Induced by Mitochondrial Dysfunction in an In Vitro Model of Axonal Injury , 2013, The Journal of Neuroscience.
[24] M. Koltzenburg,et al. Chemotherapy‐induced peripheral neurotoxicity: A critical analysis , 2013, CA: a cancer journal for clinicians.
[25] A. A. Romanovsky,et al. An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways , 2013, PAIN®.
[26] S. Pezet,et al. Structural and Molecular Alterations of Primary Afferent Fibres in the Spinal Dorsal Horn in Vincristine-Induced Neuropathy in Rat , 2013, Journal of Molecular Neuroscience.
[27] Ling Ye,et al. Knockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia , 2013, PAIN®.
[28] Z. Fei,et al. Spinal Astrocytic Activation Contributes to Mechanical Allodynia in a Rat Chemotherapy-Induced Neuropathic Pain Model , 2013, PloS one.
[29] S. Dib-Hajj,et al. Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system , 2012, PAIN®.
[30] P. Grafe,et al. Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1.6-resurgent and persistent current , 2012, Proceedings of the National Academy of Sciences.
[31] Nirmal Singh,et al. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. , 2012, Toxicology.
[32] H. Haapasalo,et al. Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy. , 2011, Anticancer research.
[33] S. Dib-Hajj,et al. Sodium channels in normal and pathological pain. , 2010, Annual review of neuroscience.
[34] N. Kiguchi,et al. Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in mice , 2008, Neuroscience Letters.
[35] T. Kondo,et al. The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice. , 2008, European journal of pharmacology.
[36] C. Loprinzi,et al. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. , 2008, European journal of cancer.
[37] G. Bennett,et al. Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitine , 2008, PAIN.
[38] Wolfgang Grisold,et al. Chemotherapy‐induced neuropathy , 2008, Journal of the peripheral nervous system : JPNS.
[39] Matthew S. Johnson,et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat , 2007, Proceedings of the National Academy of Sciences.
[40] P. Dougherty,et al. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. , 2007, Journal of pain and symptom management.
[41] G. Bennett,et al. Chemotherapy-evoked painful peripheral neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit , 2007, Neuroscience.
[42] G. Bennett,et al. Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells , 2006, Experimental Neurology.
[43] J. Sullivan,et al. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states , 2006, Pain.
[44] C. Sommer,et al. Heterozygous P0 deficiency protects mice from vincristine‐induced polyneuropathy , 2006, Journal of neuroscience research.
[45] J. Deleo,et al. Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat , 2006, Neuroscience Letters.
[46] J. Kamei,et al. Effect of mexiletine on vincristine-induced painful neuropathy in mice. , 2006, European journal of pharmacology.
[47] M. Tallman,et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. , 2005, Blood.
[48] J. Kamei,et al. Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine-induced painful neuropathy in mice , 2005, Pain.
[49] J. Heimans,et al. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening , 2005, Neurology.
[50] G. Forlani,et al. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[51] S. I. Levin,et al. Floxed allele for conditional inactivation of the voltage‐gated sodium channel Scn8a (Nav1.6) , 2004, Genesis.
[52] G. Bennett,et al. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy , 2004, Pain.
[53] S. Paul,et al. Altered temporal pattern of evoked afferent activity in a rat model of vincristine-induced painful peripheral neuropathy , 2003, Neuroscience.
[54] P. Dougherty,et al. Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia , 2003, PAIN®.
[55] Arnold H. Buss. Pathways , 2002, Journal of personality assessment.
[56] T. Yaksh,et al. Vincristine-induced allodynia in the rat , 2001, Pain.
[57] J. Levine,et al. Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine‐induced painful peripheral neuropathy in the rat , 2000, The Journal of comparative neurology.
[58] A. Eschalier,et al. Pain related behaviour during vincristine-induced neuropathy in rats. , 1999, Neuroreport.
[59] J. Levine,et al. Nociceptor Hyper-Responsiveness during Vincristine-Induced Painful Peripheral Neuropathy in the Rat , 1998, The Journal of Neuroscience.
[60] J. Levine,et al. Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine‐induced painful neuropathy in rat , 1998, The Journal of comparative neurology.
[61] J. Levine,et al. Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans , 1996, Neuroscience.
[62] T. Yaksh,et al. Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.
[63] D. Yarnitsky,et al. Full dose vincristine (without 2‐mg dose limit) in the treatment of lymphomas , 1994, Cancer.
[64] M. Jordan,et al. Mechanism of inhibition of cell proliferation by Vinca alkaloids. , 1991, Cancer research.
[65] J. Mendell,et al. Studies on the pathogenesis of vincristine‐induced neuropathy , 1987, Muscle & nerve.
[66] V. Devita,et al. Treatment of the lymphomas. , 1972, Seminars in hematology.
[67] Pieter Lagrou. States , 2019, Europe’s Postwar Periods 1989, 1945, 1918.
[68] N. Kiguchi,et al. Involvement of inflammatory mediators in neuropathic pain caused by vincristine. , 2009, International review of neurobiology.
[69] H. Hartung,et al. Chemotherapy-induced peripheral neuropathy , 2002, Journal of Neurology.